Patients
John Wyall Traveled to England for the NobleStitch Procedure
The Noblestitch did exactly what I hoped it would. I had my energy back as soon as the anesthesia wore off. |
John Wyall from Orem, Utah has suffered from a structural heart defect that has worsened in the last few years to the point that he has been bedfast for 14 to 18 hours a day for the last year and a half and unable to do much more than sit on the couch when he was able to get out of bed. After trying to get answers from numerous doctors over the years, he finally found a specialist who discovered through tests a condition in which required suturing.
It was clear to John that he needed to have his defect treated, but he was told that he didn't qualify for the current treatment. He had already had numerous episodes, and waiting to have another one was unacceptable to John. He began his research. The only approved procedure in the US was open-heart surgery. This is a very traumatic procedure that requires general anesthesia and having the heart stopped while on a heart-lung machine. This was not the option John was looking for. John had found in Europe that there was a percutaneous solution that did not require open-heart surgery. However, it required leaving a large metal implant in the heart. There were also some very dangerous potential risks associated with these implants that John did not want to take. He discovered a new technology called NobleStitch, which was developed by well-known medical device inventor Prof. Anthony Nobles. John then reached out to Dr. Michael Mullen, Consultant Cardiologist at University College Hospital London, UK, and asked if he could perform the procedure on John in London. Prof. Nobles flew to London to meet John and his wife and to be on hand with Dr. Mullen. Dr. Mullen successfully placed the suture in John’s heart and achieved a perfect suturing using the NobleStitch. The entire procedure took less than 20 minutes, and even with what is considered to be a large defect, a single suture did the job.
John has returned home to Utah and has already seen his condition returning to normal. His fatigue is gone and he has not experienced any complications or any of his pre-procedural symptoms since the procedure. He said: “The NobleStitch did exactly what I hoped it would. I had my energy back as soon as the anesthesia wore off. I was able to get up early in the morning, take a two-mile walk in the mountains with my wife, and return to my other normal activities. It’s hard to believe that until just a few days ago I’d spent 14 to 18 hours in bed every day for over 18 months. I can’t imagine even being able to do that again. Best of all, I have peace of mind knowing that I don’t have to worry about a failure-prone metal device sitting inside my heart or have to take anti-platelet medication for six months or more.”
|
Eva, a Nurse Administrator in Sweden receives NobleStitch EL Cardiac Suturing Device
Now, I hope that I can live fully with working, traveling and physical challenges. To be free from the medication and the feeling of being afraid means a lot to me. |
Swedish patient Eva has had a successful NobleStitch cardiac suturing procedure. The patient, a nurse/ administrator from the hospital and rehabilitation center in Linkoping, who has suffered from the symptoms of her structural heart defect that was being treated with aggressive medication while awaiting treatment for her condition.
Eva was scheduled for a procedure with a metal implant that would remain in her heart for life and require potentially long term anticoagulation therapy and carry some of the known risks associated with these implants. This led Eva to investigate alternative treatment. Her cardiologist Dr. Niels Erik Nielsen recommended a new device from America, the NobleStitch EL. Initially apprehensive to be the first in Sweden until Eva saw an interview with Prof. Nobles showing the NobleStitch device and then specifically requested the NobleStitch EL to treat her condition. |
It was clear to her Physician Dr. Niels Erik Nielsen, Cardiologist at the Linkoping University Hospital in Sweden that she needed to have her condition treated. Because she had already had a significant symptoms and did not want the usual type of implant in her heart. Dr. Nielsen also believed their was a better solution required for her and his other patients and having discovered the NobleStitch a year prior at the Structural Heart meeting “CSI” in Frankfurt. He began his research and contacted Prof Nobles at the congress and received initial training on the NobleStitch. Dr. Nielsen believed that the NobleStitch would be the best treatment for her rather than the metal implants, which required leaving a couple of metal implants in the heart as there were some potential risks associated with these implants that Dr. Nielsen nor his patient wanted to take.
The NobleStitch enters percutaneously through the vein in the leg and travels into the heart under fluoroscopy (X-ray) and places a suture in the cardiac tissue to suture the defect. This is the same suture that is used in the open-heart procedure, but without the surgery.
Dr. Nielsen contacted Nobles Medical to see if he could get the NobleStitch for this procedure in Sweden. After speaking with Prof. Nobles, CEO of NMT2, Prof. Nobles planned a trip to Sweden as part of the initial sales launch in Sweden and to train Dr. Nielsen on the NobleStitch EL. Dr. Michael Mullen, Consultant Cardiologist at University College Hospital London, UK and a member of the NMT2 Clinical Advisory Board who has performed more of the NobleStitch procedures than anyone in the world, flew to Sweden to proctor Dr. Nielsen who successfully placed the suture in Eva’s heart and achieved a perfect result using the NobleStitch. The entire procedure took less than 25 minutes, and a single suture did the job.
The NobleStitch enters percutaneously through the vein in the leg and travels into the heart under fluoroscopy (X-ray) and places a suture in the cardiac tissue to suture the defect. This is the same suture that is used in the open-heart procedure, but without the surgery.
Dr. Nielsen contacted Nobles Medical to see if he could get the NobleStitch for this procedure in Sweden. After speaking with Prof. Nobles, CEO of NMT2, Prof. Nobles planned a trip to Sweden as part of the initial sales launch in Sweden and to train Dr. Nielsen on the NobleStitch EL. Dr. Michael Mullen, Consultant Cardiologist at University College Hospital London, UK and a member of the NMT2 Clinical Advisory Board who has performed more of the NobleStitch procedures than anyone in the world, flew to Sweden to proctor Dr. Nielsen who successfully placed the suture in Eva’s heart and achieved a perfect result using the NobleStitch. The entire procedure took less than 25 minutes, and a single suture did the job.